Testicular cancer medical therapy

Revision as of 09:09, 29 April 2019 by Gertrude Djouka (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2], Shanshan Cen, M.D. [3]

Testicular cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Testicular cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Testicular cancer medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Testicular cancer medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Testicular cancer medical therapy

CDC on Testicular cancer medical therapy

Testicular cancer medical therapy in the news

Blogs on Testicular cancer medical therapy

Directions to Hospitals Treating Testicular cancer

Risk calculators and risk factors for Testicular cancer medical therapy

Overview

The predominant therapy for testicular cancer is surgical resection. Adjunctive chemotherapy and radiation therapy may be required.

Medical Therapy

Seminoma Stage IA and IB

  • Surveillance for pT1-T3 tumors or
  • Single agent carboplatin for 1 or 2 cycles followed with chest X-ray and CT scan of the abdomen and pelvis or
  • Radiation therapy

Stage IS

  • Recheck the serum marker and the chest X-ray and Ct scan of abdominen and pelvis

Stage IIA

Radiation therapy

  • Radiation therapy works best for seminomas. Non-seminomas do not respond well to radiation therapy.
  • External beam radiation may be used for stage I and II seminomas after orchiectomy.<ref>Testicular cancer.2015 Canadian Cancer Society.
  • Radiation treatments are usually given once a day, 5 days a week, for 2–4 weeks.

Chemotherapy

Standard-dose chemotherapy

  • The most common chemotherapy combinations used to treat testicular cancer are:
  • It is usually given IV every 3 weeks for 2–3 months, or 3 or 4 cycles. In some cases, 1 or 2 cycles may be given for stage I non-seminomas.
  • It is used when bleomycin affects the lungs or there is a high risk that it will cause lung damage. It is given IV every 3 weeks for 3 months, or 4 cycles.
  • It may be used when bleomycin affects the lungs or there is a high risk that it will cause lung damage. It is given IV every 3 weeks for 3 months, or 4 cycles.
  • If testicular cancer does not respond to the above drugs or if it recurs, the following chemotherapy combinations may be used. These are sometimes called salvage, or second-line, chemotherapy.
  • It is given IV every 3 weeks for 3 months, or 4 cycles.
  • Etoposide, ifosfamide and cisplatin.
  • It is given IV every 3 weeks for 3 months, or 4 cycles.
  • It is given IV every 3 weeks for 3 months, or 4 cycles.

High-dose chemotherapy

  • High-dose chemotherapy with carboplatin and etoposide may be used if testicular cancer recurs after it is treated with standard-dose chemotherapy.

Palliative chemotherapy

  • Palliative therapy is given to relieve symptoms, rather than to treat the cancer itself. Gemcitabine may be given with oxaliplatin, paclitaxel or both as palliative treatment for seminomas or non-seminoma.

|}

References


Template:WikiDoc Sources